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Abstract
Increased transient receptor potential canonical type 3 (TRPC3) channels have been observed in patients with essential
hypertension. In the present study we tested the hypothesis that increased monocyte migration is associated with increased
TRPC3 expression. Monocyte migration assay was performed in a microchemotaxis chamber using chemoattractants
formylated peptide Met-Leu-Phe (fMLP) and tumor necrosis factor-a (TNF-a). Proteins were identified by immunoblotting
and quantitative in-cell Western assay. The effects of TRP channel-inhibitor 2–aminoethoxydiphenylborane (2-APB) and
small interfering RNA knockdown of TRPC3 were investigated. We observed an increased fMLP-induced migration of
monocytes from hypertensive patients compared with normotensive control subjects (246614% vs 151610%). The TNF-a-
induced migration of monocytes in patients with essential hypertension was also significantly increased compared to
normotensive control subjects (221620% vs 138618%). In the presence of 2-APB or after siRNA knockdown of TRPC3 the
fMLP-induced monocyte migration was significantly blocked. The fMLP-induced changes of cytosolic calcium were
significantly increased in monocytes from hypertensive patients compared to normotensive control subjects. The fMLP-
induced monocyte migration was significantly reduced in the presence of inhibitors of tyrosine kinase and phosphoinositide
3-kinase. We conclude that increased monocyte migration in patients with essential hypertension is associated with
increased TRPC3 channels.
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Introduction
An increased transient receptor potential canonical type 3
(TRPC3) protein expression has been observed both in patients
with essential hypertension and in animal models of hypertension
[1–5]. In patients with hypertension an increased TRPC3
expression has been reported in several tissues including vascular
smooth muscle cells and peripheral blood monocytes [1,2,5]. It is
well established that monocytes play a crucial role in atherogenesis
by recruitment to the vessel wall [6]. Monocyte activation,
adhesion to the endothelium, and transmigration into the
subendothelial space are key events in early pathogenesis of
atherosclerosis [7]. Earlier studies from Doerffel et al. indicated
that monocyte activation is increased in hypertension [8].
Monocytes from patients with essential hypertension show
elevated secretion patterns of pro-inflammatory cytokines, an
increased expression of adhesion molecules, and an increased
adhesion to vascular endothelial cells [9]. Increased activation of
monocytes in hypertension may be due to increased change of
cytosolic calcium. TRPC3 channels are non-selective cation
channels mediating transplasmamembrane calcium influx [10].
TRPC3 channels are likely candidates to produce increased
activation of monocytes. An increased calcium influx through
TRPC3 channels may cause increased migration of monocytes.
However, the role of TRPC3 for regulating the migration of
monocytes has not been investigated to date. In the present study
we tested the hypothesis that increased TRPC3 channel expression
causes increased migration of monocytes from patients with
essential hypertension.
Results
Increased migration of monocytes from patients with
essential hypertension
First we evaluated the migration of monocytes using the
chemoattractants fMLP and TNF-a. Figure 1A shows represen-
tative images of the fMLP-induced migration of monocytes from
normotensive control subjects and patients with essential hyper-
PLoS ONE | www.plosone.org 1 March 2012 | Volume 7 | Issue 3 | e32628Figure 1. Increased fMLP-induced migration of monocytes from patients with essential hypertension. A, Representative microscopy
images of the migration of monocytes from hypertensive patients (upper panels) compared with normotensive control subjects (lower panels) in the
absence (left panels) or in the presence (right panels) of 2-APB (100 mmol/L). Expreriments were performed in triplicate. Migration was induced by
chemoattractant fMLP (100 nm/L). Magnification 46, bar denotes 100 mm. B, C, Summary data showing fMLP-induced or TNF-a-induced migration of
monocytes from normotensive control subjects (NT; open bars) and hypertensive patients (HT, filled bars) in the absence or presence of 2-APB
(100 mmol/L). After the incubation time the polycarbonate filter membranes were dehydrated, stained using fura2-AM and fluorescence was detected
at 510 nm emission with 360 nm excitation. Migration rates were normalized to the mean migration rate of monocytes maintained in the medium
condition (control). We observed an increased fMLP-induced or TNF-a-induced migration of monocytes from patients with essential hypertension.
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PLoS ONE | www.plosone.org 2 March 2012 | Volume 7 | Issue 3 | e32628tension. We observed an increased fMLP-induced migration of
monocytes in patients with essential hypertension compared to
normotensive control subjects (246614% vs 151610%, each
n=11, P,0.01, Figure 1B). To indicate that TRPC channels
were associated with the migration of monocytes we inhibited
TRPC channels using 2-APB [11,12,13]. In normotensive control
subjects 2-APB significantly reduced the fMLP-induced migration
to 91610%, whereas in patients with essential hypertension 2-
APB significantly reduced the fMLP-induced migration to
86613% (each n=11, P,0.05 compared to their control). The
fMLP-induced migration of monocytes was significantly reduced
in the presence of 2-APB by 65% in patients with essential
hypertension, and 40% in normotensive control subjects. The
effect of 2-APB was more pronounced in patients with essential
hypertension. In the presence of 2-APB the fMLP-induced
migration of monocytes was not significantly different in patients
with essential hypertension compared with normotensive control
subjects (P.0.05). Furthermore, the TNF-a-induced migration of
monocytes in patients with essential hypertension was also
significantly increased compared to normotensive control subjects
(221620% vs 138618%, each n=10, P,0.05). In the presence of
2-APB the TNF-a-induced migration of monocytes was signifi-
cantly reduced to 92610% in normotensive control subjects, and
in patients with essential hypertension was significantly reduced to
105612%, each n=10, p,0.05 compared to their control
conditions, Figures 1C. We also evaluated that effect of 2-APB
on spontaneous migration of monocytes. Our data showed that 2-
APB did not affect monocytes spontaneous migration (P.0.05,
Figures 1D). Therefore these data may point to a functional role
of TRPC channels for an elevated agonist-induced migration of
monocytes from patients with essential hypertension.
Increased fMLP-induced changes of intracellular calcium
in monocytes from patients with essential hypertension
The fMLP-induced changes of intracellular calcium were
almost completely abolished by 2-APB in normotensive control
subjects (Figure 2A) and patients with essential hypertension
(Figure 2B). In hypertensive patients the changes of the
F340 nm/F380 nm fluorescence ratio, which were obtained
5 minutes after administration of fMLP, were reduced from
4.2660.21 to 2.6260.19 in the presence of 2-APB. Furthermore,
in normotensive control subjects, these changes were reduced from
3.7360.15 to 2.8360.12 in the presence of 2-APB. We established
that the fMLP-induced changes of intracellular calcium concen-
tration in human monocytes were dose-dependent (Figure 2C).
The fMLP-induced changes of intracellular calcium concentration
were significantly increased in monocytes from patients with
essential hypertension compared to normotensive control subjects
(fMLP 100 nmol/L; 275642 vs. 150634; fMLP 50 nmol/L;
132615 vs. 70615; fMLP 10 nmol/L; 102626 vs. 3869; each
n=10, p,0.05). The fMLP-induced (100 nmol/L) Ca
2+ response
was elevated by 83% in patients with essential hypertension
compared to normotensive control subjects. Cation influx into
monocytes was also measured by quenching of fura-2 by Mn
2+ by
standardized techniques. Stimulation was performed with fMLP.
For each curve obtained in the presence of a stimulus, the
difference to a curve obtained in the absence of a stimulus was
calculated, thus yielding the corrected quenching curve in
monocytes from normotensive control subjects and patients with
essential hypertension (Figure 2D, 2E). Under resting conditions
the Mn
2+ influx was significantly increased in patients with
essential hypertension compared to normotensive control subjects
(10.460.8% vs.7.060.6%; NT n=6; HT n=8, p,0.05).
Furthermore, after stimulation with fMLP the Mn
2+ influx was
significantly increased in patients with essential hypertension
compared to normotensive control subjects (15.661.0% vs.
9.760.7%; NT n=6; HT n=8, p,0.01; Figure 2F)
TRPC3 knockdown reduced the agonist-induced
migration of monocytes from patients with essential
hypertension
The immunoblotting of TRPC3 in monocytes lysates to test the
specificity of the antibody for TRPC3 by antigen competition
experiments is shown in Figure 3A. Using standard western
blotting we confirmed increased TRPC3 protein expression in
monocytes from both essential hypertensive patients and hyper-
tensive patients with type 2 diabetes mellitus or metabolic
syndrome compared to normotensive control subjects
(1.3060.07 for hypertensive patients, N=8; 1.3560.11 for
hypertensive patients with type 2 diabetes mellitus or metabolic
syndrome, N=10; vs. 1.0060.11 for normotensive control
subjects, N=8; p,0.05). On the other hand TRPC3 protein
expression was not significantly increased in patients with type 2
diabetes mellitus when compared to normotensive control subjects
(0.9760.08 for patients with type 2 diabetes mellitus, N=9; vs
1.0060.11 for normotensive control subjects, N=8 p.0.05), as
shown in Figure 3B. Additional measurements were preformed
in the absence of cell permeabilization to investigate TRP channel
protein expression on the surface of the cells. We observed an
increased expression of TRPC3 channel proteins on the surface of
monocytes by 40% (1.4060.13 for patients with hypertension,
N=6; vs. 1.0060.02 for normotensive control subjects, N=6;
p,0.01). Total TRPC3 channel protein expression was also
increased in patients with hypertension. These results confirm
previous findings from our group showing increased total TRPC3
channel expression on monocytes from patients with essential
hypertension (3.2160.59 for patients with hypertension, N=20;
vs. 1.3660.07 for normotensive control subjects, N=20; p,0.05;
J Hypertens. 2006). These findings support the idea that increased
TRPC channel protein expression in patients with hypertension
increases transplasmamembrane calcium influx. Based on our
previous study [14], we performed quantitative real-time PCR
indicating that siRNA against TRPC3 significantly reduced
TRPC3 transcripts to 1162% of control (p,0.05). To verify that
TRPC3 channels are involved in monocyte migration, TRPC3
knockdown was performed by gene silencing with RNA
interference using specific siRNA or scrambled siRNA. We found
an increased TRPC3 protein expression in monocytes from
patients with essential hypertension compared to normotensive
control subjects (2.3460.08 vs. 1.2060.10; p,0.01). After siRNA
knockdown of TRPC3, the TRPC3 expression was not signifi-
cantly different in monocytes from patients with essential
hypertension and normotensive control subjects (0.8760.14 vs.
0.5960.10; each n=8, p.0.05), but there were no effects on
*p,0.05, **p,0.01 compared to chemoattractant alone in normotensive control subjects, +p.0.05 for the comparison in the presence of 2-APB NT
vs. HT. Each n=10 or 11. D; Spontaneous migrations of monocytes from normotensive control subjects (NT; open bars) and hypertensive patients
(HT, filled bars) were tested using medium or in the presence of 2-APB (100 mmol/L). The data was quantified by counting the number of cells that
had completely migrated through the membrane in six random high-power fields (HPF, 406) per well. P.0.05 compared to normotensive control
subjects. Data are percent of medium as mean 6 SEM of three independent experiments.
doi:10.1371/journal.pone.0032628.g001
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patients with essential hypertension or normotensive control
subjects (Figure 3C). After siRNA knockdown of TRPC3 by
transfection for 48 hours, the TRPC3 protein expression was
significantly reduced from 1.0060.03 to 0.2560.08 (p,0.01).
There was no effect on TRPC6 protein expression after
transfection with siRNA against TRPC3 in monocytes (from
1.0060.08 to 0.9860.04; p.0.05, Figure 3D). Furthermore,
after siRNA knockdown of TRPC3, the fMLP-induced migration
was similar in monocytes from patients with essential hypertension
and normotensive control subjects (2363 vs. 1764; each n=8,
p.0.05; Figure 3E) and there were no effects on monocytes
migration after transfection with scrambled siRNA in monocytes
from patients with essential hypertension or normotensive control
subjects. We also evaluated whether TRPC3 channels were
involved in spontaneous migration in monocytes. We treated
monocytes from normotensive control subjects and patients with
essential hypertension with small interfering RNA for knockdown
of TRPC3 or scrambled siRNA for control. We observed that
specific siRNA against TRPC3 or scrambled siRNA did not
significantly affect spontaneous migration of monocytes
(Figure 3F). This may indicate that TRPC3 does not affect so-
called spontaneous migration, but only agonist-induced migration.
Our study indicated that the agonist-induced migration is
augmented by increased TRP channels in the patients with
essential hypertension, whereas spontaneous migration may not be
affected.
We evaluated CD14CD16 monocyte subset levels in normo-
tensive control subjects and patients with essential hypertension





+ subset levels were not significantly differed
between normotensive control subjects and patients with essential
hypertension (5766% vs 5065% for CD14
++CD16
2; and
1262% vs 1362% for CD14
+CD16
+; each n=11, P.0.05;
Figure 4A). In addition, the chemotaxis using an incubation time
of 4 h was also used to test monocytes’ migration. Also for a short
incubation time of 4 hours we observed an increased fMLP-
induced migration of monocytes from patients with essential
hypertension compared to normotensive control subjects
(159612% vs 10065%; each n=8, P,0.01). We were interested
whether differences of fMLP-induced migration in patients with
essential hypertension and healthy subjects might be related to
differences in the expression of the receptor for fMLP. Our data
showed that fMLP receptors were not significantly different
between patients with essential hypertension and normotensive
control subjects (P.0.05, Figure 4B). These findings indicate that
fMLP receptors may not be responsible for the observed
differences of fMLP-induced monocytes migration between
Figure 2. Increased fMLP-induced changes of cytosolic calcium in monocytes from patients with essential hypertension. A, B;
Representative fluorescence tracings in monocytes from normotensive control subjects (A) and hypertensive patients (B) after administration of fMLP
(100 nm/L) in the absence and presence of TRP channel-inhibitor 2-APB. C; Summary data of changes of intracellular calcium concentration in
monocytes from normotensive control subjects (NT; open bars) and patients with essential hypertension (HT; filled bars) by several doses of fMLP
(10 nmol/L, 50 nmol/L, and 100 nm/L). Each n=10; *p,0.05 for the comparison HT vs. NT. D, E; fMLP-induced cation influx into monocytes indicated
by quenching of fura-2 by manganese (Mn
2+,1mmol/L). Representative raw data, showing mamganese quenching with a stimulus (fMLP, 100 nmol/
L) or without stimulus (control, w/o fMLP) in monocytes from normotensive control subjects (D; open black or grey circle; NT) and patients with
essential hypertension (E; filled black or grey circle; HT). F; Bar graph shows the summary data of manganese quenching rate obtained from
normotensive control subjects (NT, n=6) and patients with essential hypertension (HT, n=8) under the control conditions or after administration of
fMLP (100 nmol/L). *p,0.05 or **p,0.01 for the comparison with their controls; and #p,0.05 or ## p,0.01 for the comparison HT (filled bars) vs.
NT (open bars).
doi:10.1371/journal.pone.0032628.g002
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PLoS ONE | www.plosone.org 4 March 2012 | Volume 7 | Issue 3 | e32628Figure 3. Specific siRNA against TRPC3 blocks the migration in monocytes, but did not affect spontaneous migration of monocytes.
A; Immunoblot showing specificity of antibodies against TRPC3 in monocytes from normotensive control subjects (NT) and patients with essential
hypertension (HT) in the absence or presence of TRPC3 antigens (TRPC3+Ag). The predicted molecular weight of TRPC3 is 97 kDa. B; Immunoblot
showing specificity of antibodies against TRPC3 in monocytes from normotensive control subjects (NT, n=8), patients with type 2 diabetes mellitus
(DM, n=9), patients with essential hypertension (HT, n=8) or hypertensive patients with type 2 diabetes mellitus (HT+DM, n=10). Summary data of
the TRPC3 expression (normalized to GAPDH). *p,0.05, compared to NT. Data are mean 6 SEM. C; Representative in-cell western assay and summary
data of the TRPC3 expression (normalized to CD14 expression used as an internal reference) in monocytes from normotensive control subjects
(Normotensive, and opened bars, n=3) and patients with essential hypertension (Hypertensive, filled bars, n=3) under control conditions and after
transfection with scrambled siRNA or specific siRNA against TRPC3 for 48 h. In-cell western assay was performed using specific antibodies and
fluorescence-labeled secondary antibodies. TRPC3 (visible in green) normalized to CD14 (used as an internal reference). Measurements were
performed in duplicate for each sample. *p,0.05 or **p,0.01 for the comparison with their controls; and ## p,0.01 for the comparison
Hypertensive (filled bars) vs. Normotensive (open bars). D; Representative in-cell western assay and summary data of the TRPC3 and TRPC6
expression in monocytes from normotensive control subjects under control conditions and after transfection with specific siRNA against TRPC3 for
TRPC3 Increases Migration of Monocytes
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subjects. On the other hand, microscopy showed that fMLP did
not cause significant differences of the polarization response of
monocytes from healthy control subjects and patients with
hypertension (P.0.05, Figure 4C, 4D).
The role of tyrosine kinase, phosphoinositide 3-kinase
and ERK for the migration of monocytes
To evaluate the underlying pathways of the migration of
monocytes we investigated the roles of tyrosine kinase, phospho-
inositide 3-kinase (PI3K) and ERK. As shown in Figure 5A,
compared to normotensive control subjects, the fMLP-induced
migration of monocytes from patients with essential hypertension
was significantly increased (mean counts of migrated monocytes
under magnification 406; normotensive control subjects 3564,
patients with essential hypertension 5367, respectively; p,0.05).
On the other hand, the fMLP-induced migration of monocytes
was significantly reduced in the presence of the tyrosine kinase
blocker, genistein; or PI3K inhibitor, wortmannin; and an
inhibitor of ERK, PD98059 (mean counts of migrated monocytes
under magnification 406; genistein 1863, wortmannin 2063,
and PD98059 2065 in monocytes from patients with essential
hypertension; or genistein 1961, wortmannin 2062, and
PD98059 2063 in monocytes from normotensive control subjects;
p,0.01 compared to their control conditions). In the presence of
the genistein or wortmannin and PD98059, the fMLP-induced
migration of monocytes was not significantly different between
patients with essential hypertension and normotensive control
subjects (p.0.05). Genistein reduced the fMLP-induced migration
of monocytes by 46%, and wortmannin reduced it by 43% in
normotensive control subjects. Moreover, genistein reduced the
fMLP-induced migration of monocytes by 67%, and wortmannin
reduced it by 62% in patients with essential hypertension (p,0.01
compared to normotensive control subjects). Furthermore, after
siRNA transfection against TRPC3 the effects of genistein or
wortmannin could not be observed any longer (2265; or 2167
p.0.05 compared with control conditions).
The role of Akt and ERK-dependent pathways in essential
hypertension
We observed that fMLP activates monocytes by an ERK- and
Akt-dependent pathway. As shown in Figure 6, administration of
fMLP significantly increased phosphorylated ERK and phosphor-
ylated Akt in a dose-dependent and time-dependent manner
(Figure 6A and 6B). Furthermore, we compared the dose
response effects of fMLP on monocytes from patients with essential
hypertension and normotensive control subjects. We observed an
increased phosphorylated ERK (Figure 6C) and phosphorylated
Akt (Figure 6D) after fMLP stimulation of monocytes from
patients with essential hypertension compared to normotensive
control subjects. The expression of pERK was 2.7760.26 vs.
1.5560.06, n=3, P,0.05; and the expression of pAkt was
0.5660.04 vs. 0.2460.04, n=3, P,0.05 for these groups,
respectively. These findings confirmed that the fMLP-induced
activation of monocytes in patients with essential hypertension was
associated with ERK and Akt pathways.
We observed that both the inhibition of TRPC channels using
2-APB and down-regulation of TRPC3 by specific siRNA
significantly reduced the fMLP-induced expression of pERK and
pAkt (Figure 6E). These findings underscore that the fMLP-
induced activation of monocytes is TRPC3-dependent.
Discussion
The present study showed that the increased migration of
monocytes from hypertensive patients compared to normotensive
control subjects could be attributed to increased expression of
TRPC3 channels. After TRPC3 gene knockdown the fMLP-
induced migration was similar in monocytes from hypertensive
patients and normotensive control subjects.
Patients with essential hypertension show increased
activation of monocytes
The increased activation of monocytes from patients with
essential hypertension has been described by several groups.
Doerffel et al. reported that the secretion of IL-1beta and TNF-
alpha was significantly increased in peripheral blood monocytes
from hypertensive patients compared to normotensive control
subjects [8]. Marketou et al. showed increased expression of
angiopoietin-1 and 2 genes in peripheral monocytes with increased
pulse wave velocity in patients with essential hypertension [15]. An
increased monocyte chemotaxis has been observed by producing
monocyte chemoattractant protein-1 through activation of nuclear
factor-kappa B. An increased monocyte chemoattractant protein-1
expression could be observed in monocytes after stimulation of
nuclear factor-kappa B [16]. Monocyte chemoattractant protein-
1/cysteine-cysteine chemokine receptor 2 pathway appears to be
involved in the increased inflammatory response observed in
hypertension [9].
Increased TRPC3 protein expression is associated with
increased migration of monocytes from patients with
hypertension
Chronic monocyte-mediated inflammation in arterial walls is
commonly observed in hypertensive patients [17]. The migration
of monocytes is an early critical step in the atherosclerotic process
[18]. As indicated by several groups, an increased calcium influx
causes increased migration of monocytes [19]. TRPC3 channels
are cation channels mediating transplasmamembrane calcium
influx [10]. Earlier studies from our group and other groups
indicated that increased TRPC3 protein expression is a common
finding both in patients with essential hypertension and in animal
models of hypertension [1–5]. The present study extended these
observations, showing that the increased TRPC3 protein expres-
48 h. In-cell western assay was performed using specific antibodies and fluorescence-labeled secondary antibodies. TRPC3 and TRPC6 expression
(visible in green) normalized to CD14 (visible in red used as an internal reference). Measurements were performed in duplicate for each sample.
**p,0.01 compared to control conditions. Data are mean 6 SEM of three independent experiments. E; Summary data of the fMLP-induced monocyte
migration from hypertensive patients (HT, filled bars) and normotensive control subjects (NT, opened bars) quantified by counting the number of
cells that had completely migrated through the membrane in six random high-power fields (HPF, 406) per well. Monocytes chemotaxis was
expressed as the mean number of migrated cells per high-power fields from duplicate wells. Experiments were performed under control conditions,
after transfection with scrambled siRNA or specific siRNA against TRPC3. *p,0.05; **p,0.01 compared to normotensive control subjects under
control conditions. Data are mean 6 SEM of eight independent experiments. F; Spontaneous migrations of monocytes from normotensive control
subjects (NT; open bars) and hypertensive patients (HT, filled bars) were tested using medium or after transfection with scrambled siRNA or specific
siRNA against TRPC3. The data was quantified by counting the number of cells that had completely migrated through the membrane in six random
high-power fields (HPF, 406) per well. P.0.05 compared to NT. Data are percent of medium as mean 6 SEM of three independent experiments.
doi:10.1371/journal.pone.0032628.g003
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PLoS ONE | www.plosone.org 6 March 2012 | Volume 7 | Issue 3 | e32628Figure 4. Monocyte subtypes and fMLP receptors in normotensive and hypertensive patients. A, Peripheral blood monocytes
subpopulations were analyzed by flow-cytometry. After labeling with anti-CD14 phycoerythrin (PE) conjugated and anti-CD16 FITC conjugated,
monocytes from patients with essential hypertension (HT, filled bars) and normotensive control subjects (NT; open bars) were readily separated into
three distinct subsets according to CD14 and CD16 positivity. Data are mean 6 SEM, each n=11, P.0.05 NT vs. HT. B, Expression of fMLP receptors
using immunoblotting with specific antibodies. The data showed that fMLP receptors were not significantly different between in monocytes from
patients with essential hypertension (HT, filled bars) and normotensive control subjects (NT; open bars). Data are mean 6 SEM, n=6, P.0.05 NT vs.
HT. C, D, Representative micrographs of fMLP-induced polarization response of monocytes (C). Summary data of fMLP induced polarization response
of monocytes from healthy control subjects (NT; open bars) and from patients with hypertension (HT, filled bars). Data are mean 6 SEM, **p,0.01
compared to NT fMLP-stimulation (0 min); ##p,0.01 compared to HT fMLP-stimulation (0 min); P.0.05 NT vs. HT; each n=12 (D).
doi:10.1371/journal.pone.0032628.g004
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monocytes in patients with essential hypertension. We observed
that the increased fMLP-induced migration of monocytes from
hypertensive patients compared to normotensive control subjects
could be attributed to increased expression of TRPC3 channels.
We used fMLP to increase cytosolic calcium concentrations in
monocytes confirming earlier results using that substance [20,21].
We found that manganese influx was increased to almost 2 fold in
hypertensive cells. This is in agreement with previous studies
showing increased cation influx into hypertensive cells [4,5].
Furthermore, after stimulation with fMLP the decrease of the fura-2
fluorescence by manganese quenching was more pronounced in
patients with essential hypertension compared to normotensive
control subjects. Both basal and agonist-activated Mn
2+ influx were
elevated in patients with essential hypertension. More importantly
the fMLP-induced Mn
2+ quenching was in agreement with an
augmented fMLP-induced Ca
2+ response in patients with essential
hypertension compared to normotensive control subjects. Previous
studies showed that the formyl-peptide receptor (FPR) plays a
centralroleinthefluidshearstressresponseofcirculatingleukocytes
as a mechanosensor [22]. The difference of fMLP receptor
expression is almost completely absent in in mature DCs [23]. In
addition, a reduced density of the extracellular domain of the FPR
wasreported inneutrophilsfrom SHR[24].Ourdata indicated that
FPR may not be responsible for the observed differences of fMLP-
induced monocytes migration between patients with essential
hypertension and normotensive control subjects.
Several evidences support the notion that increased TRPC3 is
associated with increased migration of monocytes from patients
with essential hypertension. First, siRNA knockdown of TRPC3
significantly blocked the fMLP-induced monocyte migration.
Second, the administration of the TRPC blocker 2-APB
significantly reduced the migration of monocytes. Experimental
data from several groups indicated 2-APB blocks TRPC channels
[17,18,19]. We measured spontaneous migration as medium
without agonist (Control), out data indicating that spontaneous
migration is not affected by 2-APB. Spontaneous migration and
agonist-induced migration may be affected by several pathways.
For example, previous reports showed that inhibitors including
forskolin plus 3-isobutyl-1-methylxanthine reduced spontaneous
migration as well as agonist-induced migration [25]. Liu et al.
showed that 2-APB abolished spontaneous Ca
2+ transients [26]. 2-
APB partially inhibited LPC-mediated activation of non-selective
cation currents and chemotaxis in monocytes, indicating that
activation of non-selective cation channels may be required for
migration of LPC-stimulated monocytes [27]. 2-APB diminished
the serum-induced increase of Ca
2+ waves and inhibited cell
proliferation [28]. Specificity of TRPC3 blockers has been
questioned in the past. Therefore we also investigated the
migration of monocytes after downregulation of TRPC3 using
specific siRNA. We observed an increased fMLP-induced
migration of monocytes from hypertensive patients compared
with normotensive control subjects. After siRNA knockdown of
TRPC3 the fMLP-induced migration was similar in monocytes
from patients with essential hypertension and normotensive
control subjects. Our experimental data using the inhibitor 2-
APB were in line with our findings using siRNA for TRPC3
knockdown. Both, experiments using the inhibitor 2-APB, as well
as specific TRPC3 knockdown using the siRNA technique
supported the notion that increased monocyte migration in
patients with essential hypertension is associated with increased
TRPC3 channels. Our study confirms that TRPC3 does not affect
spontaneous migration but only agonist-induced migration in
monocytes. It may indicate that particularly the agonist-induced
migration is augmented by increased TRP channels in the patients
with essential hypertension.
Figure 5. Increased monocyte migration associated with tyrosine kinase and phosphoinositide 3-kinase (PI3K) or ERK in essential
hypertension. A; Summary data of fMLP-induced monocytes migration was quantified by counting the number of cells that had completely
migrated through the membrane in six random high-power fields (HPF, 406) per well. Monocytes chemotaxis was expressed as the mean number of
migrated cells per 406fields from duplicate wells. Experiments were performed under control conditions (fMLP, n=6), in the presence of genistein
(Geni, n=6) or wortmannin (Wort, n=6) and PD98059 (PD, n=3). Data are mean 6 SEM of three to six independent experiments. **p,0.01
compared to their chemoattractant (fMLP) alone; # p,0.05 for comparison HT (filled bars) vs. NT (open bars).
doi:10.1371/journal.pone.0032628.g005
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monocytes from patients with hypertension?
An important step for induction of migration is the phosphor-
ylation of proteins involved in cell locomotion [29]. The present
study indicates that fMLP significantly increased phosphorylated
Akt and phosphorylated ERK in a dose- and time-dependent
manner. Both phosphorylated Akt and phosphorylated ERK have
been associated with increased cell migration. The activation of
Akt and ERK subsequently enhances phosphorylation of the
regulatory myosin light chain and finally migration [30,31]. Our
data provide the first direct evidence for the involvement of PI3K,
ERK and Akt signaling pathways of chemotaxis for monocytes
migration in the patients with essential hypertension. The
specificities of genistein or wortmannin have been questioned.
Genistein may inhibit protein tyrosine kinases, bind to PPARc,
and affect potassium channels. Wortmannin may inhibit PI3K,
inhibit polo-like kinase and affect myosin light chain kinase.
Therefore our results using genistein and wortmannin can not
exclude that signal transduction pathways other then tyrosine
kinases and PI3K may be involved [32–35]. As suggested by
Noma et al. the activation of both ERK and PI3K/Akt pathways
constitute major signaling events for activation of monocytes, but
not lymphocytes [36].
Our study indicated that the fMLP-induced migration was
significantly different between hypertensive patients and normo-
tensive subjects, and the fMLP-induced phosphorylated ERK and
phosphorylated Akt responses were elevated in hypertensive
patients. These findings may indicate that ERK- and Akt-related
pathways mediated the effects on elevated migration in hyperten-
sion. Our study showed increased migration in monocytes from
hypertensive patients associated with increased TRPC3 protein
expression. Increased migration of monocytes may aggravate
atherosclerosis in hypertensive patients. It may be speculated that
reduction of blood pressure as well as amelioration of increased
TRPC3 expression in monocytes may be important goals in order
to prevent hypertensive complications.
Methods
Patient characteristics
The clinical and biochemical characteristics of normotensive
control subjects and patients with essential hypertension are
presented in Table 1. Control subjects and patients with essential
hypertension were on unrestricted normal diet with no sodium
restriction. A diagnosis of hypertension was based on systolic blood
pressure 140 mmHg or a diastolic (Korotkoff phase V) blood
Figure 6. The role of Akt and ERK-dependent pathways in essential hypertension. A, B; fMLP activates ERK or phosphorylation of ERK (A)
and Akt or phosphorylation of Akt (B) in a dose- and time-dependent manner in monocytes from normotensive control subjects. 10 nmol/L open
bars, 100 nmol/L filled bars. Data are mean 6 SEM, n=3. *p,0.05 compared to lower concentration conditions. C, D; Increased fMLP-induced
phosphorylation of ERK (C) and Akt (D) in monocytes from patients with essential hypertension. The proteins were measured using immunoblotting
with specific antibodies. Data are mean 6 SEM from three independent experiments. *p,0.05 compared to normotensive control subjects. E; fMLP
activates monocytes by an ERK-dependent and Akt-dependent pathway. Akt, ERK, or pERK and pAkt were measured using immunoblotting with
specific antibodies. In the presence of 2-APB or after administration of specific siRNA against TRPC3, the fMLP-induced ERK, pERK; Akt and pAkt were
significantly reduced when compared with control conditions. Data are mean 6 SEM from six independent experiments. *p,0.05; **p,0.01
compared to control.
doi:10.1371/journal.pone.0032628.g006
Table 1. Clinical and biochemical characteristics of normotensive control subjects and patients with essential hypertension.
Characteristic Normotensive control subjects Patients with essential hypertensive
Ages (years) 63656 5 67
N (men/women) 12/13 14/12
SBP (mmHg) 12567 15968*
DBP (mmHg) 77610 93613*
Body mass index (kg/m
2)2 4 652 8 64*
Waist circumference (cm) 79668 8 66*
Heart rate (per minute) 73697 8 610
Hemoglobin (g/dl) 138611 135616
Serum sodium (mmol/l) 13965 14066
Serum potassium (mmol/l) 3.7060.50 4.0060.50
Cholesterol (mmol/l) 4.7060.80 5.2161.09
Triglycerides (mmol/l) 0.9860.36 1.3960.68
LDL (mmol/l) 2.8060.25 2.7360.64
HDL (mmol/l) 1.6260.34 1.5660.36
FPG (mmol/l) 5.5960.64 5.9760.62
Serum creatinine (mmol/l) 74620 8267
h-sensitivity CRP (mg/L) 1.2860.69 1.5160.44
SBP: Systolic blood pressure; DBP: Diastolic blood pressure; LDL: Low-density cholesterol; HDL: High-density cholesterol; FPG: Fasting plasma glucose; Data are mean 6
SD.
*P,0.01, compared with normotensive control subjects.
doi:10.1371/journal.pone.0032628.t001
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ric methods. Blood pressure was obtained on three occasions in a
sitting position after a rest of 10 minutes. No patient had
significant pain, elevated temperature, other acute conditions, or
antihypertensive medication. Furthermore, C-reactive protein was
normal in all subjects. Diagnosis of essential hypertension was
established after exclusion of secondary forms of hypertension.
Normotensive control subjects were recruited among patients with
minor complaints. Subjects with major medical illness were
excluded. All subjects gave written informed consent and the
study was approved by the local ethics committee.
Preparation of cells
Human monocytes were obtained from heparinized blood using
superparamagnetic polystyrene beads coated with a primary
monoclonal antibody specific for the CD14 membrane antigen
expressed on human monocytes [37]. (Dynal Biotech, Hamburg,
Germany) and resuspended in Hanks balanced salt solution
containing: NaCl, 136 mmol/l; KCl, 5.40 mmol/l; KH2PO4,
0.44 mmol/l; Na2HPO4, 0.34 mmol/l; D-glucose, 5.6 mmol/l;
CaCl2, 1 mmol/l; N-2-hydroxyethyl-piperazine-N0-2-ethanesul-
fonic acid (HEPES), 10 mmol/l; pH 7.4.
Fluorescence measurements of cations
For ratiometric imaging experiments, cells were loaded with
2 mmol/l calcium-sensitive, cell-permeable, intracellular fluores-
cence dye 1-[2-(5-carboxyoxazol-2-yl)-6-aminobenzofuran-5-oxy]-
2-(20-amino-50-methylphenoxy)-ethane-N,N,N0,N0-tetraacetic acid
pentaacetoxy methyl ester (fura2/AM; Merck Biosciences, Darm-
stadt, Germany) at room temperature for 60 min and washed to
remove extraneous dye as previously described [4]. Fluorescence
measurements were performed at 510 nm emission with excitation
wavelengths of 340 nm and 380 nm (Fluoroskan Ascent Fluorom-
eter; Thermo Lab-Systems Oy, Helsinki, Finland). Quenching of
fura-2 fluorescence with manganese (1 mmol/L), Fura-2 fluores-
cence in monocytes was monitored at 510 nm using the isobestic
excitation wavelength of 360 nm. Each measurement was per-
formed for 300 s; manganese was added after 20 s and a stimulus
(fMLP 100 nmol/L) after 150 s. For each curve obtained in the
presence of a stimulus, the difference to a curve obtained in the
absence of a stimulus was calculated, and yielding the corrected
quenching curve [12,13]. Control experiments showed no signifi-
cant dye leakage out of the cells.
Quantitative determination of TRPC protein expression
using in-cell western assay
Quantitative in-cell Western assays of TRPC3 channels in
monocytes were performed using the Odyssey infrared imaging
system (Licor Biosciences, Bad Homburg, Germany) according to
the manufacturer’s recommendations [38]. Removed growth
media manually and monocytes immediately fixed with fixing
Solution (3.7% formaldehyde in 16PBS) for 20 minutes at room
temperature (RT). For permeabilization, cells were washed five
times with 16PBS containing 0.1% Triton X-100 for 5 minutes.
After that incubated with rabbit anti-TRPC3 antibodies (1:1000,
Alomone Laboratories, Jerusalem, Israel) as the primary antibod-
ies for 2 h, washed, incubated with IRDye 800 CW infrared
fluorescent dye conjugated goat anti-rabbit antibodies (1:1000,
Biomol, Hamburg, Germany) as the secondary antibody overnight
and washed, and quantitative imaging was performed at 810 nm
emission with an excitation wavelength of 780 nm. Control
experiments were performed by the omission of cell permeabiliza-
tion and omission of the primary or secondary antibodies. For
internal reference we used mouse anti-CD14 antibodies and Alexa
Fluor680-allophycocyanin fluorescence–labeled goat anti-mouse
antibodies (1:1000, MoBiTec, Go ¨ttingen, Germany). Imaging was
performed at 700 nm emission with an excitation wavelength of
680 nm. Additional measurements were performed in the absence
of cell permeabilization to investigate TRPC channel protein
expression on the cell surface.
Small interfering RNA knockdown of TRPC3
RNA interference for the down-regulation of a specific gene in
living cells by small interfering RNA (siRNA) was performed.
Human monocytes were transfected with siRNA specific for
TRPC3 for 24 or 48 h using a silencer siRNA transfection kit
(Ambion, Austin, Texas, USA) or with negative control siRNA.
Briefly, monocytes were resuspended in Advanced DMEM
(Dulbecco’s Modified Eagle Medium, Invitrogen) with 10% foetal
bovine serum and incubated with siPORT amine (Ambion) and
1 ml chemically synthesized siRNA (final concentration, 20 nmol/
l; Ambion) specific for the respective TRPC channel. The target
sequence for TRPC3 was 59 –GGUUAAACCUCUUCACU-
CAtt–39 (sense) and 59–UGAGUGAAGAGGUUUAACCtg–39
(antisense).
Monocytes were then investigated using in-cell western assays
and fluorescence measurements as described above. In control
experiments using the described transfection procedure, negative
control siRNA (Ambion) that has no significant homology to any
known human gene sequence did not affect GAPDH expression
(10062%; n=4).
Immunoblotting of TRPC3, Akt, pAkt, ERK and pERK
proteins expression
Immunoblotting was performed as previously described by our
group [1]. Monocytes were isolated and resuspended in ice-cold
lysis buffer. Cells were lysed in high-salt extraction buffer
(0.5 mol/L Tris, 1% NP-40, 1% Triton X-100, 1 g/L sodium
dodecyl sulfate, 1.5 mol/L NaCl, 0.2 mol/L EDTA, 0.01 mol/L
EGTA) and 0.2 mmol/L protease inhibitor, placed at 220uC for
20 min and centrifuged at 12,000 g at 4uC for 20 min to remove
insoluble material. Protein concentration was determined using a
DC protein assay kit (Bio-Rad, Hercules, CA, USA). Fifty-mg
portions of the protein were resolved on SDS–polyacrylamide gels
(10%) and electroblotted onto polyvinylidene difluoride mem-
branes. After transfer, the membranes were blocked for 4 hours at
room temperature in blocking buffer (Bio-Rad). The membranes
were incubated with primary antibodies against TRPC (alomone
labs; 1:200), Akt, pAkt, ERK, and pERK (Santa Cruz Biotech-
nology; 1:500) followed by incubation with secondary horseradish
peroxidase-conjugated secondary antibody. The specific bands
were quantified using an image analyzer (bio-rad laboratories,
Hercules, CA, USA). The specificity of TRPC3 antibodies was
tested using antigen competition experiments [37].
Monocyte migration assay
The monocytes chemotaxis assays were performed using a
modified 48-well Boyden microchemotaxis chamber (Neuroprobe,
Inc; Gaithersburg, MD; USA) according to the manufacturer’s
recommendations and reports from the literature [39,40]. Wells
covered with 8 mm-pore size polycarbonate membranes (Neurop-
robe, Inc) separated the upper and the lower chambers. The
camber was assembled, monocytes were resuspended in RPMI
1640 containing 0.5% BSA. 50 ml of the cell suspension (1610
6
cells/mL) was placed into the upper compartment of the
chemotaxis chamber, and monocytes were allowed to migrate
TRPC3 Increases Migration of Monocytes
PLoS ONE | www.plosone.org 11 March 2012 | Volume 7 | Issue 3 | e32628toward chemoattractant formylated peptide Met-Leu-Phe (fMLP,
100 nmol/L; Sigma-Aldrich) or tumor necrosis factor-a (TNF-a,
100 ng/mL, Sigma-Aldrich) which was placed in the lower
chamber for 4 or 48 hours at 37uC in a humidified atmosphere
(5% CO2). After the incubation time the polycarbonate filter
membranes were dehydrated, stained using fura2-AM and
fluorescence was detected at 510 nm emission with 360 nm
excitation, which is the calcium-independent fura-2 excitation
wavelength. Monocytes chemotaxis was quantified by calculating
the ratio of marginal and centrally located fluorescence. Negative
controls were performed where RPMI 1640 medium was placed in
the lower chamber. The experiments using a rapid endotoxin test
(Pyrosate, sensitivity 0.25 EU/ml, East Falmouth, Massachusetts,
USA) showed that fura2-AM was free of endotoxin. After 1-hour
incubation, gently inversion of the tubes was performed until the
occurrence of a solid gel-clot. The PPC (Positive Product Control)
tubes showed the formation of a hard gel (clot+), but SPL (Sample)
tubes did not clot. We made serial dilutions for Fura2-AM
solutions (final concentrations, 1 mmol/l, 2 mmol/l, and 4 mmol/l).
SPL tubes did not show any clot+ (i.e., the sample contains less
than 0.25 EU/ml of endotoxin).
In addition, after the incubation time the polycarbonate filter
membranes were fixed, dehydrated, stained using Harris haema-
toxylin, and mounted on a glass slide. Chemotaxis of monocytes
was quantified by counting the number of cells that had
completely migrated through the membrane into six random
squares per well (magnification 640). Chemotaxis of monocytes
was expressed as chemotaxis ratio, which is the ratio between the
cells migrated towards the chemoattractant and those migrated
towards control medium into the polycarbonate filter membranes.
Negative controls were performed where RPMI 1640 medium was
placed in the lower chamber. All experiments were performed at
least in triplicate. All data on fMLP-induced migration and TNF-
a-induced migration were analyzed based on the difference (% of
own medium control) in normotensive control subjects and
patients with hypertension.
Monocytes of pseudopod extension
To evaluate the effects of fMLP-induced monocytes shape
changes, monocytes were seeded in the cover glass and held in the
round steel chamber filled with 50 ml PBS. fMLP (final
concentration 100 nM) was added onto cover glass, which
initiated the extension of the cells pseudopod. Pseudopod
extension was observed by means of an inverted Nikon
(TE2000U, Tokyo, Japan) microscope equipped with a 406
objective. The microscope images were recorded with a charge-
coupled device (CCD) camera (Nikon, DS-5MC). A real-time
counter and recorded images were analyzed with Nikon-Elements
Imaging Software (NIS-BR3.2), and the rate of pseudopod
extension was calculated from the measured pseudopod lengths
and time lapses. The nonresponding fraction of monocyts was not
reported in the averages of the rates of pseudopod extension.
Flow Cytometric Determination of monocyte subset
100 ml of heparinized blood samples were stained with anti-
human CD14 conjugated with phycoerythrin (CD14-PE), anti-
human CD16 conjugated with fluorescein isothiocyanate (CD16-
FITC) antobodies (BD Biosciences, San Diego, Calif., USA) for
15 min at room temperature, and following lysis and washing,
flow-cytometric detection of monocyte subsets was performed
(FACS Caliber; BD Biosciences). Fifty thousand cells were
analyzed from each sample and the percentage and number of
cells out of the total monocytes were compared.
Statistics
All data were expressed as mean 6 SEM and were compared
using a two-tailed Student’s t-test. The null hypothesis was rejected
at p,0.05. Where error bars do not appear on the figure, error
was within the symbol size.
Acknowledgments
We thank Tingbing Cao and Lijuan Wang for technical assistance.
Author Contributions
Conceived and designed the experiments: DL Z. Zhu MT AS. Performed
the experiments: Z. Zhao YN JC DL HH. Analyzed the data: JZ HY XX
ZY. Contributed reagents/materials/analysis tools: Z. Zhao YN JC JZ.
Wrote the paper: DL Z. Zhu.
References
1. Liu D, Scholze A, Zhu Z, Krueger K, Thilo F, et al. (2006) Transient receptor
potential channels in essential hypertension. J Hypertens 24: 1105–1114.
2. Thilo F, Baumunk D, Krause H, Schrader M, Miller K, et al. (2009) Transient
receptor potential canonical type 3 channels and blood pressure in humans.
J Hypertens 27: 1217–1223.
3. Dietrich A, Schnitzler M, Gollasch M, Gross V, Storch U, et al. (2005) Increased
vascular smooth muscle contractility in TRPC62/2 mice. Mol Cell Biol 25:
6980–6989.
4. Liu D, Scholze A, Kreutz R, Wehland-von-Trebra M, Zidek W, et al. (2007)
Monocytes from spontaneously hypertensive rats show increased store-operated
and second messenger-operated calcium influx mediated by transient receptor
potential canonical type 3 channels. Am J Hypertens 20: 1111–1118.
5. Liu D, Yang D, He H, Chen X, Cao T, et al. (2009) Increased transient receptor
potential canonical type 3 channels in vasculature from hypertensive rats.
Hypertension 53: 70–76.
6. Ross R (1999) Atherosclerosis–an inflammatory disease. N Engl J Med 340:
115–126.
7. Wu H, Gower RM, Wang H, Perrard XY, Ma R, et al. (2009) Functional role of
CD11c+ monocytes in atherogenesis associated with hypercholesterolemia.
Circulation 119: 2708–2717.
8. Do ¨rffel Y, La ¨tsch C, Stuhlmu ¨ller B, Schreiber S, Scholze S, et al. (1999)
Preactivated peripheral blood monocytes in patients with essential hypertension.
Hypertension 34: 113–117.
9. Ishibashi M, Hiasa K, Zhao Q, Inoue S, Ohtani K, et al. (2004) Critical role of
monocyte chemoattractant protein-1 receptor CCR2 on monocytes in
hypertension-induced vascular inflammation and remodeling. Circ Res 94:
1203–1210.
10. Nilius B, Owsianik G, Voets T, Peters JA (2007) Transient receptor potential
cation channels in disease. Physiol Rev 87: 165–217.
11. Ma H, Venkatachalam K, Li H, Montell C, Kurosaki T, et al. (2001) Assessment
of the role of the inositol 1, 4, 5-trisphosphate receptor in the activation of
transient receptor potential channels and store-operated Ca
2+ entry channels.
J Biol Chem 276: 18888–18896.
12. Brechard S, Melchior C, Planc ¸on S, Schenten V, Tschirhart EJ (2008) Store-
operated Ca
2+ channels formed by TRPC1, TRPC6 and Orai1 and non-store-
operated channels formed by TRPC3 are involved in the regulation of NADPH
oxidase in HL-60 granulocytes. Cell Calcium 44: 492–506.
13. Chen X, Yang D, He H, Luo Z, Ma S, et al. (2010) Increased rhythmicity in
hypertensive arterial smooth muscle is linked to transient receptor potential
canonical channels. J Cell Mol Med 14: 2483–2494.
14. Thilo F, Scholze A, Liu D, Zidek W, Tepel M (2008) Association of transient
receptor potential canonical type 3 (TRPC3) channel transcripts with
proinflammatory cytokines. Arch Biochem Biophys 471: 57–62.
15. Marketou ME, Kontaraki JE, Tsakountakis NA, Zacharis EA, Kochiadakis GE,
et al. (2010) Arterial stiffness in hypertensives in relation to expression of
angiopoietin-1 and 2 genes in peripheral monocytes. J Hum Hypertens 24:
306–311.
16. Herna ´ndez-Presa M, Bustos C, Ortego M, Tun ˜on J, Renedo G, et al. (1997)
Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-kappa
B activation, monocyte chemoattractant protein-1 expression, and macrophage
infiltration in a rabbit model of early accelerated atherosclerosis. Circulation 95:
1532–1541.
17. Dzau VJ (2001) Theodore Cooper Lecture: Tissue angiotensin and pathobiology
of vascular disease: a unifying hypothesis. Hypertension 37: 1047–1052.
TRPC3 Increases Migration of Monocytes
PLoS ONE | www.plosone.org 12 March 2012 | Volume 7 | Issue 3 | e3262818. Gleissner CA, Leitinger N, Ley K (2007) Effects of native and modified low-
density lipoproteins on monocyte recruitment in atherosclerosis. Hypertension
50: 276–283.
19. Kim MK, Kim SD, Lee HY, Lee SY, Shim JW, et al. (2008) Collagen-binding
motif peptide, a cleavage product of osteopontin, stimulates human neutrophil
chemotaxis via pertussis toxin-sensitive G protein-mediated signaling. FEBS Lett
582: 3379–3384.
20. Bejarano I, Terro ´n MP, Paredes SD, Barriga C, Rodrı ´guez AB, et al. (2007)
Hydrogen peroxide increases the phagocytic function of human neutrophils by
calcium mobilisation. Mol Cell Biochem 296: 77–84.
21. Orie NN, Zidek W, Tepel M (1999) Chemoattractant- and mitogen-induced
generation of reactive oxygen species in human lymphocytes: the role of calcium.
Exp Physiol 84: 515–520.
22. Makino A (2006) G protein-coupled receptors serve as mechanosensors for fluid
shear stress in neutrophils. Am J Physiol Cell Physiol 290: C1633–C1639.
23. Yang D, Chen Q, Chen X, Howard OMZ, Oppenheim JJ (2000) Differential
regulation of responsiveness to fMLP and C5a upon dendritic cell maturation:
Correlation with receptor expression. Journal of Immunology 165: 2694–2702.
24. Chen AY, DeLano FA, Valdez SR, Ha JN, Shin HY, et al. (2010) Schmid-
Scho ¨nbein. Receptor cleavage reduces the fluid shear response in neutrophils of
the spontaneously hypertensive rat. Am J Physiol Cell Physiol 299:
C1441–C1449.
25. Fine JS, Byrnes HD, Zavodny PJ, Hipkin RW (2001) Evaluation of signal
transduction pathways in chemoattractant-induced human monocyte chemo-
taxis. Inflammation 25: 61–67.
26. Liu XX, Hashimoto-Torii K, Masaaki TM, Ding C, Rakic P (2010) Gap
Junctions/Hemichannels modulate interkinetic nuclear migration in the
forebrain precursors. The Journal of Neuroscience 30: 4197–4209.
27. Schilling T, Eder C (2009) Non-Selective Cation Channel Activity Is Required
for Lysophosphatidylcholine-Induced Monocyte Migration. J Cell Physiol 221:
325–334.
28. Wilkerson MK, Heppner TJ, Bonev AD, Nelson MT (2006) Inositol trispho-
sphate receptor calcium release is required for cerebral artery smooth muscle cell
proliferation. Am J Physiol Heart Circ Physiol 290: H240–H247.
29. Sieg DJ, Hauck CR, Ilic D, Klingbeil CK, Schaefer E, et al. (2000) FAK
integrates growth-factor and integrin signals to promote cell migration. Nat Cell
Biol 2: 249–256.
30. Li X, Syrovets T, Genze F, Pitterle K, Oberhuber A, et al. (2010) Plasmin
triggers chemotaxis of monocyte-derived dendritic cells through an Akt2-
dependent pathway and promotes a T-helper type-1 response. Arterioscler
Thromb Vasc Biol 30: 582–590.
31. Xi X, Graf K, Goetze S, Fleck E, Hsueh WA, et al. (1999) Central role of the
MAPK pathway in ang II-mediated DNA synthesis and migration in rat
vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 19: 73–82.
32. Ka ¨hler CM, Pischel AB, Haller T, Meierhofer C, Djanani A, et al. (2001) Signal
transduction pathways in directed migration of human monocytes induced by
human growth hormone in vitro. Int Immunopharmaco 1351–1361.
33. Mosheimer BA, Kaneider NC, Feistritzer C, Sturn DH, Wiedermann CJ (2004)
Expression and function of RANK in human monocyte chemotaxis. Arthritis
Rheum 50: 2309–2316.
34. Mosheimer BA, Kaneider NC, Feistritzer C, Djanani AM, Sturn DH, et al.
(2005) Syndecan-1 Is Involved in Osteoprotegerin-induced chemotaxis in
human peripheral blood monocytes. J Clin Endocr Metab 90(5): 2964–2971.
35. Gruen ML, Hao MM, Piston DW, Hasty AH (2007) Leptin requires canonical
migratory signaling pathways for induction of monocyte and macrophage
chemotaxis. Am J Physiol Cell Physiol 293: C1481–C1488.
36. Noma H, Kato T, Fujita H, Kitagawa M, Yamano T, et al. (2009) Calpain
inhibition induces activation of the distinct signalling pathways and cell
migration in human monocytes. Immunology 128: e487–e496.
37. Liu D, Scholze A, Zhu Z, Krueger K, Thilo F, et al. (2006) Transient receptor
potential channels in essential hypertension. J Hypertens 24: 1105–1114.
38. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, et al. (2005)
Diagnosis and management of the metabolic syndrome: an American Heart
Association/National Heart Lung, and Blood Institute scientific statement.
Circulation 112: 2735–2752.
39. Sunder-Plassmann G, Hofbauer R, Sengoelge G, Ho ¨rl WH (1996) Quantifica-
tion of leukocyte migration: improvement of a method. Immunol Invest 25:
49–63.
40. Dunzendorfer S, Kaser A, Meierhofer C, Tilg H, Wiedermann CJ (2000)
Dendritic cell migration in different micropore filter assays. Immunol Lett 71:
5–11.
TRPC3 Increases Migration of Monocytes
PLoS ONE | www.plosone.org 13 March 2012 | Volume 7 | Issue 3 | e32628